Tfifha Miniar, Ferjani Asma, Mallouli Manel, Mlika Nesrine, Abroug Saoussen, Boukadida Jalel
a Pediatric Department, Sahloul Hospital, UR02SP13 , CHU Farhat Hached , Sousse , Tunisia.
b Microbiology and Immunology Department, UR02SP13 , CHU Farhat Hached , Sousse , Tunisia.
Libyan J Med. 2018 Dec;13(1):1419047. doi: 10.1080/19932820.2017.1419047.
The pandemic spread of multidrug-resistant (MDR) bacteria (i.e., methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum b-lactamase-producing Enterobacteriaceae (ESBLPE), vancomycin-resistant enterococci, carbapenemase-producing Enterobacteriaceae (CPE), multiresistant Pseudomonas aeruginosa and multiresistant Acinetobacter baumannii) pose a threat to healthcare Worldwide. We found limited data of MDR bacteria in pediatric patients hospitalized in Tunisian tertiary healthcare.The aim of the study is to evaluate the acquisition rate of MDR acquisition during hospitalization and to explore some of the associated risk factors for both carriage and acquisition at the pediatric department, Sahloul University Hospital. During September and October 2016, newly admitted patients were screened, at admission, during care and at discharge. Risk factors for colonization were explored by multivariate analysis. Of 112 newly admitted patients, 8.92% were colonized with at least one MDR. No risk factor was identified at admission. During hospitalization, five newly acquisition MDR (4.9%) were detected and eight (7.84%) at discharge. The specie most frequently detected on admission was Escherichia coli (50%), whereas, on discharge, Escherichia coli and K. pneumoniae were the species most frequently detected (52.7%). The pediatric intensive care unit (PICU) hospitalization, the length of hospital stay (more than 3days) and age under 2 years were identified as risk factor for acquisition of MDR during hospitalization. We identified several independent risk factors for contracting MDR bacteria during hospitalization in a tertiary pediatric department. The incidence of symptomatic MDR Infection among those colonized should be under close surveillance and long-term screening for those children is required. An institutional screening program for MDR especially in PICU might be discussed in regards to cost effectiveness.
多重耐药(MDR)细菌(即耐甲氧西林金黄色葡萄球菌(MRSA)、产超广谱β-内酰胺酶肠杆菌科细菌(ESBLPE)、耐万古霉素肠球菌、产碳青霉烯酶肠杆菌科细菌(CPE)、多重耐药铜绿假单胞菌和多重耐药鲍曼不动杆菌)的大流行传播对全球医疗保健构成威胁。我们发现,在突尼斯三级医疗保健机构住院的儿科患者中,关于MDR细菌的数据有限。本研究的目的是评估住院期间MDR获得率,并探索萨赫勒大学医院儿科病房携带和获得MDR的一些相关危险因素。在2016年9月和10月期间,对新入院患者在入院时、治疗期间和出院时进行筛查。通过多变量分析探索定植的危险因素。在112名新入院患者中,8.92%至少定植有一种MDR。入院时未发现危险因素。住院期间,检测到5例新获得的MDR(4.9%),出院时检测到8例(7.84%)。入院时最常检测到的菌种是大肠杆菌(50%),而出院时,最常检测到的菌种是大肠杆菌和肺炎克雷伯菌(52.7%)。儿科重症监护病房(PICU)住院、住院时间(超过3天)和2岁以下年龄被确定为住院期间获得MDR的危险因素。我们确定了三级儿科病房住院期间感染MDR细菌的几个独立危险因素。应对那些定植者中症状性MDR感染的发生率进行密切监测,并且需要对这些儿童进行长期筛查。关于成本效益,可能需要讨论针对MDR的机构筛查计划,尤其是在PICU。